Tema Oncology ETF CANC | NASDAQ
CANC last paid $0.0196 a share on Dec 12, 2025, and returned 13.7% over 12 months with distributions counted. · 1-year total return +13.7% · Track CANC in a free portfolio
Company Overview:
3.3 Year CANC Performance Metrics:
CANC Dividend Payments & Yield
CANC Dividends Info:
Projected Future Returns & Dividends for CANC
Based on past 3.3-year performance, here are CANC growth metrics:
Share price CAGR of +104.48%
Dividend CAGR of -63.88%
Using CANC CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| CANC (DRIP) | CANC - No DRIP | |
|---|---|---|
| Current Price | $38.57 | $38.57 |
| Start Shares | 259.27 | 259.27 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 259.47 | 259.27 |
| Dividends Payment | $0.00 | $0.00 |
| Annual Dividends | $0 | $0 |
| Yield on cost | 0.00% | 0.00% |
| Share Price | $38.57 | $38.57 |
| Total Dividends | $8 | $8 |
| Final Value | $10,008 | $10,008 |
NOTE: Above numbers are our estimate based on CANC's Dividend and Price CAGR over past 3.3 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Company Info
Tema Oncology ETF (CANC) had its IPO on 2023-08-14, and is traded on NASDAQ stock exchange.
The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.
CANC website: https://temaetfs.com/canc
DCF model unavailable for CANC — no fundamentals on file (ETFs and funds are not modelable).
